tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Financial Statements

Compare
263 Followers

Gain Therapeutics Financial Overview

Gain Therapeutics's market cap is currently $49.74M. The company's EPS TTM is $-0.955; its P/E ratio is ―; Gain Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 55.18K$ 140.11K$ 164.99K$ 28.88K
Gross Profit$ 0.00$ -25.20K$ 75.94K$ -7.00M$ -2.23M
Operating Income$ -20.35M$ -22.25M$ -17.78M$ -13.83M$ -3.48M
EBITDA$ -20.35M$ -22.17M$ -17.78M$ -13.82M$ -3.47M
Net Income$ -20.41M$ -22.27M$ -17.59M$ -13.89M$ -3.58M
Balance Sheet
Cash & Short-Term Investments$ 10.39M$ 16.79M$ 20.14M$ 36.88M$ 7.49M
Total Assets$ 12.12M$ 18.61M$ 24.10M$ 38.99M$ 9.60M
Total Debt$ 214.51K$ 1.03M$ 1.27M$ 1.61M$ 1.26M
Net Debt$ -10.17M$ -10.77M$ -6.04M$ -35.27M$ -6.23M
Total Liabilities$ 4.78M$ 6.03M$ 5.22M$ 4.17M$ 3.40M
Stockholders' Equity$ 7.34M$ 12.58M$ 18.88M$ 34.82M$ 6.20M
Cash Flow
Free Cash Flow$ -22.49K$ -18.88M$ -14.81M$ -12.46M$ -3.26M
Operating Cash Flow$ 0.00$ -18.87M$ -14.69M$ -12.37M$ -3.24M
Investing Cash Flow$ 4.98M$ 10.22M$ -14.77M$ -94.21K$ -20.83K
Financing Cash Flow$ 13.01M$ 12.64M$ -78.77K$ 41.77M$ 10.49M
Currency in USD

Gain Therapeutics Earnings and Revenue History

Gain Therapeutics Debt to Assets

Gain Therapeutics Cash Flow

Gain Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis